XML 91 R72.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Segments of Business (Details)
£ in Millions, $ in Millions, $ in Millions
3 Months Ended 9 Months Ended
Dec. 11, 2019
USD ($)
May 23, 2018
USD ($)
May 23, 2018
CAD ($)
Dec. 31, 2019
USD ($)
country
Sep. 30, 2019
USD ($)
Jun. 30, 2019
USD ($)
Dec. 31, 2018
USD ($)
Jun. 30, 2018
USD ($)
Dec. 31, 2019
USD ($)
segment
country
Dec. 31, 2018
USD ($)
Dec. 31, 2019
GBP (£)
country
Sep. 30, 2019
GBP (£)
Mar. 31, 2019
USD ($)
Mar. 31, 2019
GBP (£)
Dec. 31, 2018
GBP (£)
Segment Reporting Information [Line Items]                              
Long-term debt outstanding       $ 7,700         $ 7,700       $ 7,600    
Number of reportable segments | segment                 3            
Revenues                              
Total Revenues       59,172     $ 56,208   $ 172,516 $ 161,890          
Operating profit                              
Total operating profit       360     683   1,620 1,455          
Corporate Expenses, Net       (211)     (190)   (750) (480)          
Interest Expense       (64)     (67)   (184) (194)          
Income (Loss) from Continuing Operations Before Income Taxes       294     650   (57) 1,243          
Pre-tax credits related to LIFO accounting                 114 64          
Proceeds from legal settlements             104     139          
Pre-tax charge related to customer bankruptcy             60     60          
Goodwill and other asset impairment charges       30     35   113 671          
Asset impairment Charge, net of tax       30     35                
Pretax goodwill impairment charges       2     21   2 591          
After-tax goodwill impairment                   591          
Net income (loss) from Change Healthcare       28     50   1,478 162          
Net restructuring, impairment and related charges recognized       136     110   204 288          
Net restructuring, impairment and related charges recognized, after tax       115     92   167 244          
U.S. Pharmaceutical and Specialty Solutions                              
Operating profit                              
Pre-tax credits related to LIFO accounting       66     21   114 64          
After-tax credit related to LIFO accounting       $ 49     16   84 47          
Pretax goodwill impairment charges                 $ 0            
European Pharmaceutical Solutions                              
Segment Reporting Information [Line Items]                              
Number of countries in which entity segment operates | country       13         13   13        
Operating profit                              
Goodwill and other asset impairment charges       $ 64         $ 64            
Asset impairment Charge, net of tax       53         53            
Pretax goodwill impairment charges                 0 570          
After-tax goodwill impairment               $ 570   570          
Medical-Surgical Solutions                              
Operating profit                              
Pretax goodwill impairment charges                 0            
Other                              
Operating profit                              
Pretax goodwill impairment charges                 2            
Operating Segments                              
Revenues                              
Total Revenues       59,172     56,208   172,516 161,890          
Operating profit                              
Total operating profit       569     907   877 1,917          
Operating Segments | U.S. Pharmaceutical and Specialty Solutions                              
Revenues                              
Total Revenues       46,923     44,279   137,067 126,866          
Operating profit                              
Total operating profit       $ 687     $ 671   $ 1,905 $ 1,824          
Revenue derived from services, percentage (less than)       1.00%     1.00%   1.00% 1.00%          
Operating Segments | European Pharmaceutical Solutions                              
Revenues                              
Total Revenues       $ 6,931     $ 6,911   $ 20,239 $ 20,485          
Operating profit                              
Total operating profit       $ (303)     $ 26   $ (297) $ (524)          
Revenue derived from services, percentage (less than)       10.00%     10.00%   10.00% 10.00%          
Operating Segments | Medical-Surgical Solutions                              
Revenues                              
Total Revenues       $ 2,141     $ 2,012   $ 6,100 $ 5,663          
Operating profit                              
Total operating profit       $ 124     $ 136   $ 378 $ 334          
Revenue derived from services, percentage (less than)       2.00%     2.00%   2.00% 2.00%          
Operating Segments | Other                              
Revenues                              
Total Revenues       $ 3,177     $ 3,006   $ 9,110 $ 8,876          
Operating profit                              
Total operating profit       61     74   (1,109) 283          
Joint Venture                              
Operating profit                              
Pre-tax dilution loss from reduction of ownership                 (246)            
Pre-tax credit recognized on relief from potential future obligations                   90          
After-tax credit recognized on relief from potential future obligations                   66          
Joint Venture | Change Healthcare JV                              
Operating profit                              
Pre-tax impairment charge                 1,200            
After-tax impairment charge                 864            
Net income (loss) from Change Healthcare       28     50   75 162          
United States                              
Revenues                              
Total Revenues       49,310     46,523   143,924 133,186          
Foreign                              
Revenues                              
Total Revenues       9,862     9,685   28,592 28,704          
Canada | Other                              
Operating profit                              
Net restructuring charges recognized                   89          
Net restructuring charges recognized, after tax                   83          
Rexall Health                              
Operating profit                              
Goodwill and other asset impairment charges             56   32 56          
Asset impairment Charge, net of tax             56   32 56          
Third Party Seller of Rexall Health | Rexall Health | Canada                              
Operating profit                              
Escrow settlement gain, pre-tax   $ 97 $ 125             97          
Escrow settlement gain, net of tax                   97          
United States | Pension Plan                              
Operating profit                              
Pre-tax settlement expense         $ 105 $ 17     122            
After-tax settlement expense         $ 78 $ 12     90            
Related to Two Counties                              
Operating profit                              
Pre-tax litigation and other-related expenses                 82            
After-tax litigation and other-related expenses                 61            
In re: National Prescription Opioid Litigation                              
Operating profit                              
Pre-tax litigation and other-related expenses       36         190            
Enterprise Information Solutions                              
Operating profit                              
Pre-tax gain on sale of equity method investment             56                
After-tax gain on sale of equity method investment             41                
Strategic Growth Initiative Plan - Relocation of Corporate Headquarters                              
Operating profit                              
Net restructuring, impairment and related charges recognized             31     31          
Net restructuring, impairment and related charges recognized, after tax             $ 23     $ 23          
Held-for-sale | German Wholesale Joint Venture                              
Operating profit                              
Impairment loss $ 282     282         282            
Impairment loss, after tax $ 282     $ 282         $ 282            
British Pound Sterling Denominated Notes | Term Loan                              
Segment Reporting Information [Line Items]                              
Long-term debt outstanding | £                     £ 450 £ 450   £ 450 £ 450